Quit your job.
Go to Arctic.

You might think it is dangerous, unknown, too risky. Well, life is short, why not make the most of it? That is our philosophy. And perhaps that is why Arctic, in just 10 years, has become one of the leading independent investment banks in the Nordic market.

Arctic Securities was established in Norway in 2007 by Mads H. Syversen (formerly SEB Enskilda / Orkla Finans), together with a group of colleagues.
10 years later, Arctic has become a full-service Nordic investment bank with a strong capital markets presence and comprehensive client base.

Arctic reached a milestone in 2017, with revenue exceeding NOK 1 billion. The absolute commitment to integrity, quality, competence and long-term client relationships is the foundation of the company’s success, and the reason Arctic has become a preferred and trusted discussion partner for its clients.

Arctic’s corporate culture is founded on a strong entrepreneurial and opportunistic spirit, with a commitment to continuous development and improvement. By investing in its people and human capital for the long run, Arctic has built a platform for strong future growth and continued high-quality services for its clients.

With an organization of over 200 dedicated professionals and close cooperation between the offices and product offerings, Arctic is ready for expansion in every market. As a key component of its growth strategy, Arctic is seeking new talented employees who align with the company’s core values and wish to be a part of its continued success.

Openings at Arctic

News and latest activity

News and latest activity

Wed 20 Mar 2019

Offerings - Eurocine Vaccines AB (publ) – Rights issue of SEK 15.6m

Arctic Securities is acting as financial advisor in relation to the 90 percent secured rights issue of SEK 15.6m for the Swedish listed vaccine company Eurocine Vaccines AB (publ). Eurocine Vaccines AB (publ) is referred to as “Eurocine Vaccines” or “the Company”. Shareholders have pre-emptive rights to subscribe for shares. Three (3) existing shares held on the record date of March 21, 2019, entitles to five (5) new shares. Subscription price of SEK 0.11 per share. The subscription period runs 25 March – 8 April, 2019. The rights issue is secured up to 90 percent through subscription- and guarantee undertakings. A Swedish memorandum and subscription note will be available before the subscription period on Eurocine Vaccines website, www.eurocine-vaccines.com and Arctic Securities website.

Mon 11 Mar 2019

News - Norwegian Air Shuttle ASA - NOK 2,996 million - Rights Issue

Arctic acted as Joint Bookrunner in relation to the underwritten rights issue of 90,781,318 new shares in Norwegian Air Shuttle ASA.

Tue 26 Feb 2019

News - "And the nominees are..."

Is that time of the year again, and Arctic is proud to announce that Arctic Nordic Equities is nominated to Morningstar Award in the category "Nordic Equities" for sale in Norway. The Morningstar Awards will take place March 7.

Thu 28 Feb 2019

News - Cxense ASA - NOK 90 million - Rights Issue

Arctic Securities acted as Sole Global Coordinator in relation to the fully underwritten rights issue of 12,857,142 new shares in Cxense ASA.

Latest from Twitter